Presence of cerebral microbleeds is associated with cognitive decline in acromegaly.
Presence of cerebral microbleeds is associated with cognitive decline in acromegaly.
复制标题
DOI:
10.3389/fonc.2022.948971
复制
发表时间:
2022
影响因子:
4.7
通讯作者:
Liu, Jieping
中科院分区:
文献类型:
--
作者:
Xie, Zhengxing;Zhuang, Yan;Zhang, Zongqiang;Liu, Jieping
关键词:
Cognitive decline in acromegaly has gained increasing attention. Cerebral microbleeds (CMBs) as radiographic markers for microvascular injury have been linked to various types of cognitive decline. However, the association between CMB formation and acromegaly has not yet been quantified. This study is designed to investigate the prevalence and the radiographic patterns of CMBs and the association between cognitive function and acromegaly-related CMBs in growth hormone (GH)-secreting pituitary adenoma, which is characterized by acromegaly. In a cohort of 55 patients with GH-secreting pituitary adenoma (acromegaly) and 70 healthy control (HC) patients, we determined the presence of CMBs using a 3.0-T MRI scanner. The numbers, locations, and grades of CMBs were determined via susceptibility-weighted imaging (SWI) and the Microbleed Anatomical Rating Scale. Obstructive sleep apnea (OSA) was assessed using the criteria of the American Academy of Sleep Medicine (AASM) Scoring Manual Version 2.2. The Montreal Cognitive Assessment (MoCA) was used to assess cognitive performance within 3 days of admission. The association between CMBs and cognitive function as well as clinical characteristics was explored. The incidence of CMBs was 29.1%, whereas that of OSA was 65.5% in acromegaly. There was a statistically significant difference in the prevalence of CMBs between subjects with and without acromegaly (29.1% and 5.3%, respectively) (p < 0.01). The age of acromegaly patients with CMBs was much younger compared with HCs with CMBs. Compared with HCs, a significant cognitive decline and the occurrence of OSA were demonstrated in patients with acromegaly (p < 0.01). Binary logistic regression analysis adjusted for age, education, and body mass index (BMI) revealed that CMB was an independent risk factor for cognitive impairment in patients with acromegaly (OR = 3.19, 95% CI 1.51–6.76, p = 0.002). Furthermore, in the logistic regression models adjusted for age, BMI, diabetes, and hypertension, OSA was independently associated with the occurrence of CMBs in patients with acromegaly (OR = 13.34, 95% CI 3.09–57.51, p = 0.001). A significant increase of CMBs was demonstrated in patients with acromegaly, which may be a result of OSA in acromegaly. The present study indicated that increasing CMBs are responsible for cognitive decline in patients with acromegaly.
登录
查看更多内容
影响因子:
2.2
作者:
Celik D;Duyar SS;Aksu F;Firat S;Ciftci B
通讯作者:
Ciftci B
影响因子:
11
作者:
Pasi, Marco;Casolla, Barbara;Cordonnier, Charlotte
通讯作者:
Cordonnier, Charlotte
影响因子:
3.7
作者:
Wennberg, A.;Lorusso, R.;Maffei, P.
通讯作者:
Maffei, P.
DOI:
10.1016/j.jstrokecerebrovasdis.2020.105404
发表时间:
2021-09
期刊:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
影响因子:
--
作者:
Fisher M
通讯作者:
Fisher M
影响因子:
8.2
作者:
Giustina A;Barkhoudarian G;Beckers A;Ben-Shlomo A;Biermasz N;Biller B;Boguszewski C;Bolanowski M;Bollerslev J;Bonert V;Bronstein MD;Buchfelder M;Casanueva F;Chanson P;Clemmons D;Fleseriu M;Formenti AM;Freda P;Gadelha M;Geer E;Gurnell M;Heaney AP;Ho KKY;Ioachimescu AG;Lamberts S;Laws E;Losa M;Maffei P;Mamelak A;Mercado M;Molitch M;Mortini P;Pereira AM;Petersenn S;Post K;Puig-Domingo M;Salvatori R;Samson SL;Shimon I;Strasburger C;Swearingen B;Trainer P;Vance ML;Wass J;Wierman ME;Yuen KCJ;Zatelli MC;Melmed S
通讯作者:
Melmed S